WO2022223515 - COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 3 (NR1H3) EXPRESSION
National phase entry:
Publication Number
WO/2022/223515
Publication Date
27.10.2022
International Application No.
PCT/EP2022/060238
International Filing Date
19.04.2022
Title **
[English]
COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 3 (NR1H3) EXPRESSION
[French]
COMPOSITIONS ET PROCÉDÉS POUR INHIBER L'EXPRESSION DE L'ÉLÉMENT 3 DU GROUPE H DE LA SOUS-FAMILLE 1 DE RÉCEPTEUR NUCLÉAIRE (NR1H3)
Applicants **
NOVO NORDISK A/S
DICERNA PHARMACEUTICALS, INC.
Inventors
SAXENA, Utsav
DUDEK, Henryk
PURSELL, Natalie, Wayne
SPIEGELMAN, Nicole, Alexis
LATTA, Markus, Robert
ANDERSEN, Birgitte
Priority Data
63/176,814
19.04.2021
US
21213711.1
10.12.2021
EP
21186366.7
19.07.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4582 | |
| EPO | Filing, Examination, Granting | 17327 | |
| Japan | Filing, Examination, Granting | 2201 | |
| South Korea | Filing, Examination, Granting | 2187 | |
| USA | Filing, Examination, Granting | 10590 |
Total:
36,887
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
expression.[French]
.